I agree that this site is using cookies. You can find further informations here.
X
Levy‐Bachelot, L
108  results:
Search for persons X
?
1

POSB171 Using French Administrative Database to Identify Pa..:

Francois, E ; Bensimon, L ; Cagnan, L...
Value in Health.  25 (2022)  1 - p. S127 , 2022
Link: https://doi.org/10.1016/..
 
?
2

POSB47 Hospital Management and Costs of Unresectable/Locall..:

Francois, E ; Bensimon, L ; Cagnan, L...
Value in Health.  25 (2022)  1 - p. S68-S69 , 2022
Link: https://doi.org/10.1016/..
 
?
3

POSA11 Ceftolozane-Tazobactam for the Treatment of Complica..:

Ruimy, R ; Akrich, B ; Bourge, X...
Value in Health.  25 (2022)  1 - p. S19-S20 , 2022
Link: https://doi.org/10.1016/..
 
?
4

EPH56 Trends in Human Papillomavirus (HPV) Vaccine Coverage..:

Belhassen, M ; Bensimon, L ; Jacoud, F...
Value in Health.  25 (2022)  12 - p. S202 , 2022
Link: https://doi.org/10.1016/..
 
?
5

PCV25 Hospital Costs of Balloon Pulmonary Angioplasty (BPA)..:

Cottin, V. ; Bensimon, L. ; Raguideau, F....
Value in Health.  23 (2020)  - p. S491 , 2020
Link: https://doi.org/10.1016/..
 
?
6

PCN64 Cost-Effectiveness of Pembrolizumab (KEYTRUDA®) in Co..:

Chouaid, C. ; Bensimon, L. ; Tardu, J....
Value in Health.  23 (2020)  - p. S433 , 2020
Link: https://doi.org/10.1016/..
 
?
7

PIN91 Ceftolozane-Tazobactam for the Treatment of Pneumonia..:

Levy-Bachelot, L. ; Castan, B. ; Akrich, B....
Value in Health.  23 (2020)  - p. S560 , 2020
Link: https://doi.org/10.1016/..
 
?
8

PCV82 Characteristics and Outcomes of Patients with Chronic..:

Lamia, B. ; Dallongeville, J. ; Bensimon, L....
Value in Health.  23 (2020)  - p. S501 , 2020
Link: https://doi.org/10.1016/..
 
?
9

Identifying chronic thromboembolic pulmonary hypertension t..:

Cottin, V. ; Avot, D. ; Lévy-Bachelot, L....
PLOS ONE.  14 (2019)  4 - p. e0214649 , 2019
Link: https://doi.org/10.1371/..
 
?
10

French hospital discharge database (PMSI) and bacterial res..:

de Léotoing, L. ; Barbier, F. ; Dinh, A....
Médecine et Maladies Infectieuses.  48 (2018)  7 - p. 465-473 , 2018
Link: https://doi.org/10.1016/..
 
?
11

PRS12 - DEVELOPMENT AND VALIDATION OF AN ALGORITHM IDENTIFY..:

Cottin, V. ; Teal, S. ; Avot, D....
Value in Health.  21 (2018)  - p. S405-S406 , 2018
Link: https://doi.org/10.1016/..
 
?
12

Excess mortality between 2007 and 2014 among patients withC..:

Barbut, F. ; Bouée, S. ; Longepierre, L....
Journal of Hospital Infection.  98 (2018)  1 - p. 21-28 , 2018
Link: https://doi.org/10.1016/..
 
?
13

PGI12 - PREDICTORS OF READMISSION FOR RECURRENT CLOSTRIDIUM..:

Duburcq, A. ; Barbier, F. ; Dinh, A....
Value in Health.  21 (2018)  - p. S143 , 2018
Link: https://doi.org/10.1016/..
 
?
14

CN5 - COST-EFFECTIVENESS OF PEMBROLIZUMAB VERSUS STANDARD-O..:

Chouaid, C. ; Bensimon, L. ; Clay, E....
Value in Health.  21 (2018)  - p. S4 , 2018
Link: https://doi.org/10.1016/..
 
?
15

PO-120: Head and neck cancers are associated with poor EQ-5..:

Schwarzinger, M. ; Huguet, F. ; Témam, S....
Radiotherapy and Oncology.  122 (2017)  - p. 57 , 2017
Link: https://doi.org/10.1016/..
 
1-15